en Experimental Neurobiology

Cited by CrossRef (6)

  1. Anna-Lena Hillje, Jens C Schwamborn. Utilization of stem cells to model Parkinson's disease – current state and future challenges. Future Neurology 2016;11:171
    https://doi.org/10.2217/fnl.16.7
  2. Perandones C, Pellene LA, Giugni JC, Calvo DS, RainaGB, Cuevas SM, Mata IF, Zabetian CP, Caputo M, Corach D, Micheli FE, Radrizzani M. Hypothesis: Somatic Mosaicism and Parkinson Disease. Exp Neurobiol 2015;24:173
    https://doi.org/10.5607/en.2015.24.2.173
  3. Zahra Mortezaei, Jean‐Baptiste Cazier, Ali Ashraf Mehrabi, Chao Cheng, Ali Masoudi‐Nejad. Novel putative drugs and key initiating genes for neurodegenerative disease determined using network‐based genetic integrative analysis. J Cell Biochem 2019;120:5459
    https://doi.org/10.1002/jcb.27825
  4. Jung Hwan Shin, Hyeyoung Park, Gwan Hee Ehm, Woong Woo Lee, Ji Young Yun, Young Eun Kim, Jee-Young Lee, Han-Joon Kim, Jong-Min Kim, Beom Seok Jeon, Sung-Sup Park, Ralf Krahe. The Pathogenic Role of Low Range Repeats in SCA17. PLoS ONE 2015;10:e0135275
    https://doi.org/10.1371/journal.pone.0135275
  5. Chai K. Lim, Francisco J. Fernández-Gomez, Nady Braidy, Cristina Estrada, Cristina Costa, Silvia Costa, Alban Bessede, Emiliano Fernandez-Villalba, Anna Zinger, Maria Trinidad Herrero, Gilles J. Guillemin. Involvement of the kynurenine pathway in the pathogenesis of Parkinson’s disease. Progress in Neurobiology 2017;155:76
    https://doi.org/10.1016/j.pneurobio.2015.12.009
  6. María-Trinidad Herrero, Cristina Estrada, Layal Maatouk, Sheela Vyas. Inflammation in Parkinson’s disease: role of glucocorticoids. Front. Neuroanat. 2015;9
    https://doi.org/10.3389/fnana.2015.00032